Gyre Therapeutics (GYRE) Tax Provisions (2010 - 2026)
Gyre Therapeutics (GYRE) reported Tax Provisions of $621000.0 for Q1 2026, down 31.08% year-over-year from $901000.0 in Q1 2025, and down 52.23% quarter-over-quarter from $1.3 million in Q4 2025.
Gyre Therapeutics (GYRE) Tax Provisions (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 8 years of Tax Provisions data on file, last reported at $621000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $621000.0, down 31.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 16.35% YoY), and the FY2025 annual result was $4.6 million, down 14.36% from the prior year.
- Tax Provisions declined to $621000.0 in Q1 2026 per GYRE's latest filing, from $1.3 million in the prior quarter.
- Over five years, Tax Provisions peaked at $5.1 million in Q4 2022 and troughed at $203000.0 in Q4 2024.
- A 5-year average of $1.7 million and a median of $1.4 million in 2024 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions plunged 86.29% in 2023, then jumped 540.39% in 2025.
- A 5-year view of Tax Provisions shows it stood at $5.1 million in 2022, then sank by 86.29% to $699000.0 in 2023, then plunged by 70.96% to $203000.0 in 2024, then jumped by 540.39% to $1.3 million in 2025, then plunged by 52.23% to $621000.0 in 2026.
- Business Quant data shows GYRE's Tax Provisions at $621000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | 621,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 621,000.00 |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 662,000.00 |
| Mar 31, 2025 | 901,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Dec 31, 2023 | 699,000.00 |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Mar 31, 2015 | 21,000.00 |
| Dec 31, 2014 | -56,000.00 |
| Sep 30, 2014 | 11,000.00 |
| Jun 30, 2014 | 45,000.00 |
| Mar 31, 2014 | 3.41 Mn |
| Dec 31, 2010 | 1.13 Mn |